Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

BACKGROUND: The vascular effects exerted by GLP-1 are mediated by several synergistic mechanisms such as involvement of nitric oxide and natriuresis. Recently, it was demonstrated that atrial natriuretic peptide (ANP) is essential for the glucagon-like peptide-1 (GLP-1)-stimulated vascular smooth mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathanson, David, Frick, Mats, Ullman, Bengt, Nyström, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709886/
https://www.ncbi.nlm.nih.gov/pubmed/26759609
http://dx.doi.org/10.1186/s13098-015-0116-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709886/
https://www.ncbi.nlm.nih.gov/pubmed/26759609
http://dx.doi.org/10.1186/s13098-015-0116-2

Ejemplares similares